Glenmark Pharma cracks 4%; Delhi HC bars company from selling drug Zita
Delhi High Court restrained Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed the patent of the American company.